Ipratropium Bromide and Albuterol Sulfate NDC 69097-840

Product information

Brand name (proprietary)

Ipratropium Bromide and Albuterol Sulfate

Generic name (nonproprietary)

ipratropium bromide and albuterol sulfate

Active ingredients

Ipratropium bromide — .5 mg/3mLAlbuterol sulfate — 2.5 mg/3mL

Dosage form

Solution

Route

Respiratory (Inhalation)

Labeler

Cipla USA Inc.

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 202496

Marketing start

Jun 1, 2020

Listing expires

Dec 31, 2026

Other FDA classes

Adrenergic beta2-Agonists (Mechanism)Cholinergic Antagonists (Mechanism)

Identifiers

Product ID 69097-840_14b7dfcc-b3a8-4027-9544-8d52ec2aacf3SPL ID 14b7dfcc-b3a8-4027-9544-8d52ec2aacf3SPL set ID 89d59bd9-c826-413c-8ed9-a1521a0c7cc5RxCUI 1437702UNII J697UZ2A9J, 021SEF3731

Pharmacologic class

Anticholinergic; beta2-Adrenergic Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N469097084053 followed by a unit qualifier and the quantity Copy

Package 69097-0840-53. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Other NDCs under ANDA 202496

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.